CASSAVA SCIENCES INC - Common Stock (SAVA)

Historical Holders from Q1 2019 to Q3 2025

Symbol: SAVA on Nasdaq
Type / Class: Equity / Common Stock
Shares outstanding: 48,331,225
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 13,777,140
Holdings value: $40,070,990
% of all portfolios: 0%
Number of holders: 100
Number of buys: 39
Number of sells: -45
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of CASSAVA SCIENCES INC - Common Stock (SAVA)

Filer	Ownership	Holdings Value	Nb Shares	Reporting Name	Report Period
Nachtrab Matthew	4.7%	$3,560,189	2,267,636	Nachtrab Matthew	16 Aug 2024
VANGUARD GROUP INC	4.49%	$3,927,830	2,170,072	The Vanguard Group	30 Jun 2025
BlackRock, Inc.	3.2%	$2,797,129	1,545,375	BlackRock, Inc.	30 Jun 2025

Institutional Holders of CASSAVA SCIENCES INC - Common Stock (SAVA)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	13,777,140	$40,070,990	+$5,019,405	$1,101,435	$2,913,492	$2.91	100
2025 Q2	12,246,863	$22,166,624	-$6,209,960	$815,233	$1,270,548	$1.81	96
2025 Q1	15,768,881	$23,653,533	-$3,650,996	$1,267,905	$2,012,355	$1.5	114
2024 Q4	17,411,806	$41,096,950	-$26,811,358	$17,862,520	$7,513,992	$2.36	135
2024 Q3	14,006,298	$412,343,524	+$21,408,686	$178,413,916	$80,685,694	$29.43	159
2024 Q2	13,297,542	$164,180,761	+$20,340,671	$18,969,600	$14,542,125	$12.35	140
2024 Q1	11,593,879	$235,338,414	-$49,008,344	$18,853,468	$27,133,817	$20.29	141
2023 Q4	13,929,974	$313,474,831	+$20,318,834	$40,085,808	$49,600,785	$22.51	150
2023 Q3	12,909,705	$214,797,641	+$17,325,070	$42,116,968	$45,163,488	$16.64	136
2023 Q2	11,697,131	$286,735,353	-$6,324,947	$34,543,534	$31,485,888	$24.52	150
2023 Q1	11,914,630	$287,373,528	+$15,058,161	$31,884,668	$32,313,212	$24.12	140
2022 Q4	11,254,249	$332,457,243	+$2,217,261	$72,843,064	$68,738,838	$29.54	146
2022 Q3	10,511,058	$439,522,416	+$28,422,554	$102,064,642	$142,913,972	$41.82	164
2022 Q2	9,860,019	$277,264,167	-$22,312,348	$72,704,904	$66,579,276	$28.12	136
2022 Q1	10,487,576	$389,768,314	-$39,764,775	$141,252,186	$78,442,360	$37.14	147
2021 Q4	11,534,283	$504,052,860	-$49,487,683	$195,963,000	$145,576,000	$43.7	160
2021 Q3	12,113,852	$751,991,955	+$67,636,793	$294,845,000	$265,558,000	$62.08	169
2021 Q2	10,434,065	$891,498,117	+$48,315,268	$123,442,600	$174,814,600	$85.44	163
2021 Q1	10,158,803	$456,594,941	+$91,884,258	$42,736,000	$58,038,050	$44.95	116
2020 Q4	9,404,804	$64,135,775	+$15,501,397	$3,228,000	$1,391,000	$6.82	70
2020 Q3	6,699,572	$77,113,513	+$9,133,318	$3,872,000	$6,323,000	$11.51	63
2020 Q2	5,994,033	$18,463,673	-$2,167,955	$734,000	$965,000	$3.08	47
2020 Q1	6,007,016	$24,760,000	+$5,851,160	$197,000	$521,000	$4.11	38
2019 Q4	4,360,623	$22,674,000	+$6,170,969			$5.2	27
2019 Q3	1,823,694	$2,188,000	-$1,850,994			$1.2	16
2019 Q2	3,351,011	$4,055,000	+$2,993			$1.21	20
2019 Q1	3,342,185	$4,312,000	+$4,312,000			$1.29	22